HIV/Aids

03 September 2007

Drug fights resistant HIV

A new HIV drug is effective in suppressing the Aids-causing virus in people who haven't responded to other therapies, reports say.

0
The new Merck & Co. HIV drug Isentress (raltegravir) is effective in suppressing the Aids-causing virus in people who haven't responded to other therapies, the Bloomberg news service reported Friday, citing staff reviewer documents on the US Food and Drug Administration Web site.

An FDA expert advisory panel is slated to meet on 5 September to decide whether to recommend approval of the drug.

Isentress uses a different method than existing drugs to combat HIV. It blocks the process that the virus uses to insert genetic material into a person's DNA, which allows the virus to reproduce, Bloomberg said.

In two recent trials, the drug "reduced the virus to almost undetectable levels" after four months in as many as 62 percent of patients who took it in combination with other HIV medications, the news service said. That compared with up to 36 percent of patients who took a non-medicinal placebo along with the other HIV treatments. – (HealthDayNews)

Read more:
HIV/Aids Centre

September 2007

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

HIV/Aids expert

Dr Sindisiwe van Zyl qualified at the University of Pretoria in 2005. She is a patients' rights activist and loves using social media to teach about HIV. She is in private practice in Johannesburg.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules